참고문헌 (56)

1. Wiwanitkit V. Cancer nanotherapy: concept for design of new drug J. Med. Hypotheses Ideas 2013 7 3 4 10.1016/j.jmhi.2012.10.002 10.1016/j.jmhi.2012.10.002 

   상세보기

2. Ediriwickrema A. Saltzman W. M. Nanotherapy for Cancer: Targeting and Multifunctionality in the Future of Cancer Therapies ACS Biomater. Sci. Eng. 2015 1 64 78 10.1021/ab500084g 10.1021/ab500084g 25984571 

   상세보기

3. Goodman L. S. Wintrobe M. M. Dameshek W. Goodman M. J. Gilman A. McLennan M. T. Nitrogen mustard therapy: use of methyl-bis(beta-chloroethyl)amine hydrochloride and tris(beta-chloroethyl)amine hydrochloride for hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders J. Am. Med. Assoc. 1946 132 126 132 10.1001/jama.1946.02870380008004 10.1001/jama.1946.02870380008004 20997191 

   

4. Elbashir S. M. Harborth J. Lendeckel W. Yalcin A. Weber K. Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells Nature 2001 411 494 10.1038/35078107 10.1038/35078107 11373684 

   상세보기

5. Minke B. Wu C.-F. Pak W. Continuous cultures of fused cells secreting antibody of predefined specificity Nature 1975 254 84 87 10.1038/253600a0 10.1038/258084a0 810728 

   상세보기

6. Rizzoli G. Gregio L. Mazzucco A. Stritoni P. Fracasso A. Brumana T. Gallucci V. Determinants of late survival of 105 patients operated for dissection of the aorta Eur. J. Cardiothorac. Surg. 1988 2 18 24 10.1016/1010-7940(88)90091-7 10.1016/1010-7940(88)90091-7 3272195 

   상세보기

7. Peer D. Karp J. M. Hong S. Farokhzad O. C. Margalit R. Langer R. Nanocarriers as an emerging platform for cancer therapy Nat. Nanotechnol. 2007 2 751 760 10.1038/nnano.2007.387 10.1038/nnano.2007.387 18654426 

   상세보기

8. Biswas A. K. Islam M. R. Choudhury Z. S. Mostafa A. Kadir M. F. Nanotechnology based approaches in cancer therapeutics Adv. Nat. Sci. Nanosci. Nanotechnol. 2014 5 043001 10.1088/2043-6262/5/4/043001 10.1088/2043-6262/5/4/043001 

   상세보기

9. Costa D. F. Mendes L. P. Torchilin V. P. The effect of low- and high-penetration light on localized cancer therapy Adv. Drug Deliv. Rev. 2018 138 105 116 10.1016/j.addr.2018.09.004 10.1016/j.addr.2018.09.004 30217518 

   상세보기

10. Kreuter J. Nanoparticles-a historical perspective Int. J. Pharm. 2007 331 1 10 10.1016/j.ijpharm.2006.10.021 10.1016/j.ijpharm.2006.10.021 17110063 

    상세보기

11. Singh A. Talekar M. Tran T.-H. Samanta A. Sundaram R. Amiji M. Combinatorial approach in the design of multifunctional polymeric nano-delivery systems for cancer therapy J. Mater. Chem. B 2014 2 8069 8084 10.1039/C4TB01083C 10.1039/C4TB01083C 32262094 

    상세보기

12. Wiwanitkit V. , Advanced nanomedicine and nanobiotechnology , 2008 

13. Prasad R. Yadav A. S. Gorain M. Chauhan D. S. Kundu G. C. Srivastava R. Selvaraj K. Graphene Oxide Supported Liposomes as Red Emissive Theranostics for Phototriggered Tissue Visualization and Tumor Regression ACS Appl. Bio Mater. 2019 2 3312 3320 10.1021/acsabm.9b00335 10.1021/acsabm.9b00335 

    상세보기

14. Opoku-Damoah Y. Wang R. Zhou J. Ding Y. Versatile nanosystem-based cancer theranostics: design inspiration and predetermined routing Theranostics 2016 6 986 1003 10.7150/thno.14860 10.7150/thno.14860 27217832 

    상세보기

15. Huang R. Vider J. Serganova I. Blasberg R. G. Sloan M. Cancer K. Sloan M. Cancer K. Cancer nanomedicine: progress, challenges and opportunities Nat. Rev. Cancer 2014 10 215 226 10.1038/nrc.2016.108.Cancer 

    

16. Anderson D. S. Sydor M. J. Fletcher P. Holian A. Nanotechnology: The Risks and Benefits for Medical Diagnosis and Treatment J. Nanomed. Nanotechnol. 2016 7 e143 10.4172/2157-7439.1000 

    

17. Barenholz Y. Doxil® - the first FDA-approved nano-drug: lessons learned J. Controlled Release 2012 160 117 134 10.1016/j.jconrel.2012.03.020 10.1016/j.jconrel.2012.03.020 22484195 

    상세보기

18. Sneider A. VanDyke D. Paliwal S. Rai P. Remotely Triggered Nano-Theranostics For Cancer Applications Nanotheranostics 2017 1 1 22 10.7150/ntno.17109 10.7150/ntno.17109 28191450 

    상세보기

19. Makadia H. K. Siegel S. J. Poly Lactic- co -Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier Polymers 2011 3 1377 1397 10.3390/polym3031377.Poly 10.3390/polym3031377 22577513 

    상세보기

20. Danhier F. Ansorena E. Silva J. M. Coco R. Le Breton A. Préat V. PLGA-based nanoparticles: an overview of biomedical applications J. Controlled Release 2012 161 505 522 10.1016/j.jconrel.2012.01.043 10.1016/j.jconrel.2012.01.043 22353619 

    상세보기

21. Jain R. A. The manufacturing techniques of various drug loaded biodegradable poly(lactide- co -glycolide) (PLGA) devices Biomaterials 2000 21 2475 2490 10.1016/S0142-9612(00)00115-0 10.1016/S0142-9612(00)00115-0 11055295 

    상세보기

22. Lu J.-M. Wang X. Marin-Muller C. Wang H. Lin P. H. Yao Q. Chen C. Current advances in research and clinical applications of PLGA-based nanotechnology Expert Rev. Mol. Med. 2009 9 325 341 10.1586/erm.09.15.Current 10.1586/erm.09.15 19435455 

    

23. Choi J. S. Seo K. Yoo J. W. Recent advances in PLGA particulate systems for drug delivery J. Pharm. Invest. 2012 42 155 163 10.1007/s40005-012-0024-5 10.1007/s40005-012-0024-5 

    원문보기 상세보기

24. Passerini N. Craig D. Q. M. An investigation into the effects of residual water on the glass transition temperature of polylactide microspheres using modulated temperature DSC J. Control. Release. 2001 73 111 115 10.1016/S0168-3659(01)00245-0 10.1016/S0168-3659(01)00245-0 11337064 

    상세보기

25. Mattheolabakis G. Milane L. Singh A. Amiji M. M. Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine J. Drug Targeting 2015 23 605 618 10.3109/1061186X.2015.1052072 10.3109/1061186X.2015.1052072 26453158 

    상세보기

26. Deed R. Rooney P. Kumar P. Norton J. D. Smith J. Freemont A. J. Kumar S. Early-response gene signalling is induced by angiogenic oligosaccharides of hyaluronan in endothelial cells. Inhibition by non-angiogenic, high- molecular-weight hyaluronan Int. J. Cancer 1997 71 251 256 10.1002/(SICI)1097-0215(19970410)71:2<251::AID-IJC21>3.0.CO;2-J 10.1002/(SICI)1097-0215(19970410)71:2<251::AID-IJC21>3.0.CO;2-J 9139851 

    상세보기

27. Bollyky P. L. Falk B. A. Wu R. P. Buckner J. H. Wight T. N. Nepom G. T. Intact extracellular matrix and the maintenance of immune tolerance: high molecular weight hyaluronan promotes persistence of induced CD4+CD25+ regulatory T cells J. Leukocyte Biol. 2009 86 567 572 10.1189/jlb.0109001 10.1189/jlb.0109001 19401397 

    상세보기

28. Wolny P. M. Banerji S. Gounou C. Brisson A. R. Day A. J. Jackson D. G. Richter R. P. Analysis of CD44-hyaluronan interactions in an artificial membrane system: insights into the distinct binding properties of high and low molecular weight hyaluronan J. Biol. Chem. 2010 285 30170 30180 10.1074/jbc.M110.137562 10.1074/jbc.M110.137562 20663884 

    상세보기

29. Huang G. Huang H. Application of hyaluronic acid as carriers in drug delivery Drug Deliv. 2018 25 766 772 10.1080/10717544.2018.1450910 10.1080/10717544.2018.1450910 29536778 

    상세보기

30. Kim J. Moon M. Kim D. Heo S. Jeong Y. Hyaluronic Acid-Based Nanomaterials for Cancer Therapy Polymers 2018 10 1133 10.3390/polym10101133 10.3390/polym10101133 30961058 

    상세보기

31. Tao H. Zhang Y. Zeng X. Shulman G. I. Jin S. Niclosamide ethanolamine–induced mild mitochondrial uncoupling improves diabetic symptoms in mice Nat. Med. 2014 20 1263 1269 10.1038/nm.3699 10.1038/nm.3699 25282357 

    상세보기

32. Li Y. Li P. K. Roberts M. J. Arend R. C. Samant R. S. Buchsbaum D. J. Multi-targeted therapy of cancer by niclosamide: a new application for an old drug Cancer Lett. 2014 349 8 14 10.1016/j.canlet.2014.04.003 10.1016/j.canlet.2014.04.003 24732808 

    상세보기

33. Shuai K. Horvath C. M. Huang L. H. T. Qureshi S. A. Cowburn D. Darnell J. E. Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions Cell 1994 76 821 828 10.1016/0092-8674(94)90357-3 10.1016/0092-8674(94)90357-3 7510216 

    상세보기

34. Clevers H. Nusse R. Wnt/β-catenin signaling and disease Cell 2012 149 1192 1205 10.1016/j.cell.2012.05.012 10.1016/j.cell.2012.05.012 22682243 

    상세보기

35. Guertin D. A. Sabatini D. M. Defining the Role of mTOR in Cancer Cancer Cell 2007 12 9 22 10.1016/j.ccr.2007.05.008 10.1016/j.ccr.2007.05.008 17613433 

    상세보기

36. Naugler W. E. Karin M. NF-κB and cancer - identifying targets and mechanisms Curr. Opin. Genet. Dev. 2008 18 19 26 10.1016/j.gde.2008.01.020 10.1016/j.gde.2008.01.020 18440219 

    상세보기

37. Shih I. M. Wang T. L. Notch signaling, gamma-secretase inhibitors, and cancer therapy Cancer Res. 2007 67 1879 1882 10.1158/0008-5472.CAN-06-3958 10.1158/0008-5472.CAN-06-3958 17332312 

    상세보기

38. Ramalho M. J. Pereira M. C. Preparation and Characterization of Polymeric Nanoparticles: An Interdisciplinary Experiment J. Chem. Educ. 2016 93 1446 1451 10.1021/acs.jchemed.5b00837 10.1021/acs.jchemed.5b00837 

    상세보기

39. Sun S. Liu P. Shao F. Miao Q. Formulation and evaluation of PLGA nanoparticles loaded capecitabine for prostate cancer Int. J. Clin. Exp. Med. 2015 8 19670 19681 26770631 

40. Gajra B. Dalwadi C. Patel R. Formulation and optimization of itraconazole polymeric lipid hybrid nanoparticles (Lipomer) using box behnken design Daru, J. Pharm. Sci. 2015 23 1 15 10.1186/s40199-014-0087-0 10.1186/s40199-015-0089-6 25582169 

    상세보기

41. Yadav K. S. Sawant K. K. Modified Nanoprecipitation Method for Preparation of Cytarabine-Loaded PLGA Nanoparticles AAPS PharmSciTech 2010 11 1456 1465 10.1208/s12249-010-9519-4 10.1208/s12249-010-9519-4 20842542 

    상세보기

42. Pereira M. C. Hill L. E. Carlos R. Mertens-talcott S. Talcott S. Gomes C. L. LWT - Food Science and Technology Nanoencapsulation of hydrophobic phytochemicals using poly(DL-lactide- co -glycolide)(PLGA) for antioxidant and antimicrobial delivery applications: guabiroba fruit ( Campomanesia xanthocarpa O. Berg) study LWT-Food Sci. Technol. 2015 63 100 107 10.1016/j.lwt.2015.03.062 10.1016/j.lwt.2015.03.062 

    상세보기

43. Bavya M. C. Vimal Rohan K. Gaurav G. B. Srivasatava R. Synergistic treatment strategies to combat resistant bacterial infections using Schiff base modified nanoparticulate - hydrogel system Mater. Sci. Eng. C 2018 95 226 235 10.1016/j.msec.2018.10.080 10.1016/j.msec.2018.10.080 30573245 

    상세보기

44. George L. Bavya M. C. Rohan K. V. Srivastava R. A therapeutic polyelectrolyte–vitamin C nanoparticulate system in polyvinyl alcohol–alginate hydrogel: an approach to treat skin and soft tissue infections caused by Staphylococcus aureus Colloids Surf., B 2017 160 315 324 10.1016/j.colsurfb.2017.09.030 10.1016/j.colsurfb.2017.09.030 28950196 

    상세보기

45. Liu L. Cao F. Liu X. Wang H. Zhang C. Sun H. Wang C. Leng X. Song C. Kong D. Ma G. Hyaluronic Acid-Modified Cationic Lipid-PLGA Hybrid Nanoparticles as a Nanovaccine Induce Robust Humoral and Cellular Immune Responses ACS Appl. Mater. Interfaces 2016 8 11969 11979 10.1021/acsami.6b01135 10.1021/acsami.6b01135 27088457 

    상세보기

46. Bhushan B. Dubey P. Kumar S. U. Sachdev A. Matai I. Gopinath P. Bionanotherapeutics: niclosamide encapsulated albumin nanoparticles as a novel drug delivery system for cancer therapy RSC Adv. 2015 5 12078 12086 10.1039/C4RA15233F 10.1039/C4RA15233F 

    상세보기

47. Okassa L. N. Marchais H. Douziech-Eyrolles L. Hervé K. Cohen-Jonathan S. Munnier E. Soucé M. Linassier C. Dubois P. Chourpa I. Optimization of iron oxide nanoparticles encapsulation within poly(d,l-lactide- co -glycolide) sub-micron particles Eur. J. Pharm. Biopharm. 2007 67 31 38 10.1016/j.ejpb.2006.12.020 10.1016/j.ejpb.2006.12.020 17289360 

    상세보기

48. Shen M. Y. Chao C. F. Wu Y. J. Wu Y. H. Huang C. P. Li Y. K. A design for fast and effective screening of hyaluronidase inhibitor using gold nanoparticles Sens. Actuators B Chem. 2013 181 605 610 10.1016/j.snb.2013.02.054 10.1016/j.snb.2013.02.054 

    상세보기

49. Van Tonder E. C. Maleka T. S. P. Liebenberg W. Song M. Wurster D. E. De Villiers M. M. Preparation and physicochemical properties of niclosamide anhydrate and two monohydrates Int. J. Pharm. 2004 269 417 432 10.1016/j.ijpharm.2003.09.035 10.1016/j.ijpharm.2003.09.035 14706253 

    상세보기

50. Martínez-Zaguilán R. Seftor E. A. Seftor R. E. B. Chu Y. W. Gillies R. J. Hendrix M. J. C. Acidic pH enhances the invasive behavior of human melanoma cells Clin. Exp. Metastasis 1996 14 176 186 10.1007/BF00121214 10.1007/BF00121214 8605731 

    상세보기

51. Xu L. Fukumura D. Jain R. K. Acidic extracellular pH induces vascular endothelial growth factor (VEGF) in human glioblastoma cells via ERK1/2 MAPK signaling pathway. Mechanism of low pH-induced VEGF J. Biol. Chem. 2002 277 11368 11374 10.1074/jbc.M108347200 10.1074/jbc.M108347200 11741977 

    상세보기

52. Shen Y. Tang H. Radosz M. Van Kirk E. Murdoch W. J. PH-responsive nanoparticles for cancer drug delivery Methods Mol. Biol. 2008 437 183 216 10.1007/978-1-59745-210-6_10 10.1007/978-1-59745-210-6_10 18369970 

    상세보기

53. Qhattal H. S. S. Liu X. Characterization of CD44-mediated cancer cell uptake and intracellular distribution of hyaluronan-grafted liposomes Mol. Pharm. 2011 8 1233 1246 10.1021/mp2000428 10.1021/mp2000428 21696190 

    상세보기

54. Amorim S. Soares D. Freitas D. Reis C. A. Reis R. L. Pashkuleva I. Pires R. A. Molecular weight of surface immobilized hyaluronic acid influences CD44-mediated binding of gastric cancer cells Sci. Rep. 2018 1 11 10.1038/s41598-018-34445-0 29311619 

    상세보기

55. Cadenas E. Mitochondrial free radical production and cell signaling Mol. Asp. Med. 2004 25 17 26 10.1016/j.mam.2004.02.005 10.1016/j.mam.2004.02.005 15051313 

    상세보기

56. Simon H.-U. Haj-Yehia A. Levi-Schaffer F. Role of reactive oxygen species (ROS) in apoptosis induction Apoptosis 2000 5 415 418 10.1023/A:1009616228304 10.1023/A:1009616228304 11256882 

    상세보기